Picture of Amedisys logo

AMED — Amedisys News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeMid CapSuper Stock

Amedisys Inc expected to post earnings of $1.03 a share - Earnings Preview

* Amedisys Inc  AMED.OQ   AMED.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 13
(estimated) for the period ending December 31 2023
    * The Baton Rouge Louisiana-based  company is expected to
report a
1.0% increase in revenue to $567.713 million from $562.06
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Amedisys Inc is for
earnings
of $1.03 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Amedisys
Inc is
$101.00​, above​ its last closing price of $93.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  1.06        1.08       0.98      Missed  -9.2
 Jun. 30 2023  1.09        1.09       1.37      Beat    25.5
 Mar. 31 2023  0.88        0.88       1.00      Beat    13.1​
 Dec. 31 2022  0.97        1.00       1.16      Beat    15.5
 ​​Sep.        1.21        1.22       1.15      Missed  -5.5
 30 2022                                                
 Jun. 30 2022  1.23        1.23       1.47      Beat    19.5​
 Mar. 31 2022  1.12        1.12       1.23      Beat    9.4
 Dec. 31 2021  1.19        1.18       1.18      Met     0.3
 This summary was machine generated February 9 at 11:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Amedisys

See all news